Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and,... see more

TSXV:MDX - Post Discussion

Medx Health Corp > Given the sales in Q2, $ 229 per day on average for Siascopy
View:
Post by Dunworkin2 on Aug 26, 2021 6:43am

Given the sales in Q2, $ 229 per day on average for Siascopy

Is this Board and Management team doing a good job?

Zero public market stock buying in the last 5 years!

Oh, and funny thing is that the new CEO, former Chief Revenue Officer, was hired May 1, so was around for 2/3 of Q2 results. Start proving yourself Sylvain. Start by buying some stock and not holding out for the C suite options.

Per Sedar:

16. For the six months ended June 30, 2021, the Company incurred costs for management and Board compensation of $180,889 (2020 - $243,890).


17. SUBSEQUENT EVENTS On August 16, 2021, at an Annual and Special Meeting of Shareholders, shareholders approved an amendment to the Company’s 2014 Incentive Stock Option Plan to increase the number of shares available under the plan from 26,000,000 to 30,000,000, subject to regulatory approval.
Comment by melvination on Aug 28, 2021 5:42pm
Nobody wants their wares, t'is all. They should scream due to the pandemic when all else fails. They are pathetic bottom feeders in Brazil and Mexico deep, but do not have pop in Europe
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities